000152992 001__ 152992
000152992 005__ 20240229120021.0
000152992 0247_ $$2doi$$a10.1186/s13058-019-1231-z
000152992 0247_ $$2ISSN$$a1465-5411
000152992 0247_ $$2ISSN$$a1465-542X
000152992 0247_ $$2altmetric$$aaltmetric:72730371
000152992 0247_ $$2pmid$$apmid:31829264
000152992 037__ $$aDKFZ-2020-00089
000152992 082__ $$a610
000152992 1001_ $$00000-0002-1257-9799$$aSinn, Bruno Valentin$$b0
000152992 245__ $$aHuman leucocyte antigen class I in hormone receptor-positive, HER2-negative breast cancer: association with response and survival after neoadjuvant chemotherapy
000152992 260__ $$aLondon$$bBioMed Central$$c2019
000152992 3367_ $$2DRIVER$$aarticle
000152992 3367_ $$2DataCite$$aOutput Types/Journal article
000152992 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1578475895_27265
000152992 3367_ $$2BibTeX$$aARTICLE
000152992 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000152992 3367_ $$00$$2EndNote$$aJournal Article
000152992 536__ $$0G:(DE-HGF)POF3-899$$a899 - ohne Topic (POF3-899)$$cPOF3-899$$fPOF III$$x0
000152992 588__ $$aDataset connected to CrossRef
000152992 7001_ $$aWeber, Karsten E.$$b1
000152992 7001_ $$aSchmitt, Wolfgang Daniel$$b2
000152992 7001_ $$aFasching, Peter A.$$b3
000152992 7001_ $$aSymmans, William Fraser$$b4
000152992 7001_ $$aBlohmer, Jens-Uwe$$b5
000152992 7001_ $$aKarn, Thomas$$b6
000152992 7001_ $$aTaube, Eliane Tabea$$b7
000152992 7001_ $$0P:(DE-HGF)0$$aKlauschen, Frederick$$b8
000152992 7001_ $$aMarmé, Frederik$$b9
000152992 7001_ $$aSchem, Christian$$b10
000152992 7001_ $$aStickeler, Elmar$$b11
000152992 7001_ $$aAtaseven, Beyhan$$b12
000152992 7001_ $$aHuober, Jens$$b13
000152992 7001_ $$avon Minckwitz, Gunter$$b14
000152992 7001_ $$aSeliger, Barbara$$b15
000152992 7001_ $$0P:(DE-HGF)0$$aDenkert, Carsten$$b16
000152992 7001_ $$aLoibl, Sibylle$$b17
000152992 773__ $$0PERI:(DE-600)2041618-0$$a10.1186/s13058-019-1231-z$$gVol. 21, no. 1, p. 142$$n1$$p142$$tBreast cancer research$$v21$$x1465-542X$$y2019
000152992 909CO $$ooai:inrepo02.dkfz.de:152992$$pVDB
000152992 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b8$$kDKFZ
000152992 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b16$$kDKFZ
000152992 9131_ $$0G:(DE-HGF)POF3-899$$1G:(DE-HGF)POF3-890$$2G:(DE-HGF)POF3-800$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bProgrammungebundene Forschung$$lohne Programm$$vohne Topic$$x0
000152992 9141_ $$y2019
000152992 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bBREAST CANCER RES : 2017
000152992 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000152992 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000152992 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000152992 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central
000152992 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000152992 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000152992 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000152992 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000152992 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000152992 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal
000152992 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ
000152992 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Peer review
000152992 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ
000152992 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bBREAST CANCER RES : 2017
000152992 9201_ $$0I:(DE-He78)L201-20160331$$kL201$$lDKTK Berlin$$x0
000152992 980__ $$ajournal
000152992 980__ $$aVDB
000152992 980__ $$aI:(DE-He78)L201-20160331
000152992 980__ $$aUNRESTRICTED